Contrast Enhanced Echocardiography Therapeutics
1. Definity patent expiration
Treatment: Method of using the drug substance/drug product for ultrasound imaging
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8685441 | LANTHEUS MEDCL | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
Jan, 2019
(6 years ago) | |
| US5585112 | LANTHEUS MEDCL | Method of preparing gas and gaseous precursor-filled microspheres |
Dec, 2013
(12 years ago) | |
| US6033645 | LANTHEUS MEDCL | Methods for diagnostic imaging by regulating the administration rate of a contrast agent |
Jun, 2016
(9 years ago) | |
| US5527521 | LANTHEUS MEDCL | Low density microspheres and suspensions and their use as contrast agents for computed tomography and in other applications |
Feb, 2015
(10 years ago) | |
| US9545457 | LANTHEUS MEDCL | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
Jan, 2019
(6 years ago) | |
| US8658205 | LANTHEUS MEDCL | Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
Jun, 2019
(6 years ago) | |
| US11925695 | LANTHEUS MEDCL | Methods for making ultrasound contrast agents |
Mar, 2037
(11 years from now) | |
| US10588988 | LANTHEUS MEDCL | Methods and devices for preparation of ultrasound contrast agents |
May, 2037
(11 years from now) | |
| US9789210 | LANTHEUS MEDCL | Methods for making ultrasound contrast agents |
Mar, 2037
(11 years from now) | |
| US10583207 | LANTHEUS MEDCL | Lipid-encapsulated gas microsphere compositions and related methods |
Dec, 2035
(9 years from now) | |
| US10583208 | LANTHEUS MEDCL | Methods for making ultrasound contrast agents |
Mar, 2037
(11 years from now) | |
| US11529431 | LANTHEUS MEDCL | Methods for making ultrasound contrast agents |
Mar, 2037
(11 years from now) | |
| US11857646 | LANTHEUS MEDCL | Methods for making ultrasound contrast agents |
Mar, 2037
(11 years from now) | |
| US11266750 | LANTHEUS MEDCL | Methods for making ultrasound contrast agents |
Mar, 2037
(11 years from now) | |
| US12161730 | LANTHEUS MEDCL | Methods for making ultrasound contrast agents |
Mar, 2037
(11 years from now) | |
Drugs and Companies using PERFLUTREN ingredient
Market Authorisation Date: 31 July, 2001
Dosage: INJECTABLE
More Information on Dosage
DEFINITY family patents
